These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 28610824)

  • 1. Safety and perception: What are the greatest enemies of HPV vaccination programmes?
    Bonanni P; Zanella B; Santomauro F; Lorini C; Bechini A; Boccalini S
    Vaccine; 2018 Aug; 36(36):5424-5429. PubMed ID: 28610824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating Reports of Complex Regional Pain Syndrome: An Analysis of HPV-16/18-Adjuvanted Vaccine Post-Licensure Data.
    Huygen F; Verschueren K; McCabe C; Stegmann JU; Zima J; Mahaux O; Van Holle L; Angelo MG
    EBioMedicine; 2015 Sep; 2(9):1114-21. PubMed ID: 26501109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reports of Postural Orthostatic Tachycardia Syndrome After Human Papillomavirus Vaccination in the Vaccine Adverse Event Reporting System.
    Arana J; Mba-Jonas A; Jankosky C; Lewis P; Moro PL; Shimabukuro TT; Cano M
    J Adolesc Health; 2017 Nov; 61(5):577-582. PubMed ID: 29061232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Present status of human papillomavirus vaccine development and implementation.
    Herrero R; González P; Markowitz LE
    Lancet Oncol; 2015 May; 16(5):e206-16. PubMed ID: 25943065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of human papillomavirus vaccines: a review.
    Stillo M; Carrillo Santisteve P; Lopalco PL
    Expert Opin Drug Saf; 2015 May; 14(5):697-712. PubMed ID: 25689872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reported adverse events in girls aged 13-16 years after vaccination with the human papillomavirus (HPV)-16/18 vaccine in the Netherlands.
    van Klooster TM; Kemmeren JM; van der Maas NA; de Melker HE
    Vaccine; 2011 Jun; 29(28):4601-7. PubMed ID: 21549785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burden of disease associated with cervical cancer in malaysia and potential costs and consequences of HPV vaccination.
    Aljunid S; Zafar A; Saperi S; Amrizal M
    Asian Pac J Cancer Prev; 2010; 11(6):1551-9. PubMed ID: 21338196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase
    Chandler RE; Juhlin K; Fransson J; Caster O; Edwards IR; Norén GN
    Drug Saf; 2017 Jan; 40(1):81-90. PubMed ID: 27638661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of bivalent human papillomavirus (HPV) vaccine safety and tolerability in a sample of 25 year old Tuscan women.
    Levi M; Bonanni P; Burroni E; Bechini A; Boccalini S; Sani C; Bonaiuti R; Indiani L; Azzari C; Lippi F; Carozzi F;
    Hum Vaccin Immunother; 2013 Jul; 9(7):1407-12. PubMed ID: 23571176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges.
    Poljak M
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():64-9. PubMed ID: 22862799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus vaccine introduction--the first five years.
    Markowitz LE; Tsu V; Deeks SL; Cubie H; Wang SA; Vicari AS; Brotherton JM
    Vaccine; 2012 Nov; 30 Suppl 5():F139-48. PubMed ID: 23199957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine: a randomized, controlled trial in adolescent girls.
    Medina DM; Valencia A; de Velasquez A; Huang LM; Prymula R; García-Sicilia J; Rombo L; David MP; Descamps D; Hardt K; Dubin G;
    J Adolesc Health; 2010 May; 46(5):414-21. PubMed ID: 20413076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of Human Papillomavirus Vaccines: An Updated Review.
    Phillips A; Patel C; Pillsbury A; Brotherton J; Macartney K
    Drug Saf; 2018 Apr; 41(4):329-346. PubMed ID: 29280070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tracking the global spread of vaccine sentiments: the global response to Japan's suspension of its HPV vaccine recommendation.
    Larson HJ; Wilson R; Hanley S; Parys A; Paterson P
    Hum Vaccin Immunother; 2014; 10(9):2543-50. PubMed ID: 25483472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine in healthy Indian women.
    Bhatla N; Suri V; Basu P; Shastri S; Datta SK; Bi D; Descamps DJ; Bock HL;
    J Obstet Gynaecol Res; 2010 Feb; 36(1):123-32. PubMed ID: 20178538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cluster analysis of serious adverse event reports after human papillomavirus (HPV) vaccination in Danish girls and young women, September 2009 to August 2017.
    Ward D; Thorsen NM; Frisch M; Valentiner-Branth P; Mølbak K; Hviid A
    Euro Surveill; 2019 May; 24(19):. PubMed ID: 31088598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervarix®: a bivalent vaccine against HPV types 16 and 18, with cross-protection against other high-risk HPV types.
    Szarewski A
    Expert Rev Vaccines; 2012 Jun; 11(6):645-57. PubMed ID: 22873123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: a partially-blind randomised placebo-controlled study.
    Denny L; Hendricks B; Gordon C; Thomas F; Hezareh M; Dobbelaere K; Durand C; Hervé C; Descamps D
    Vaccine; 2013 Nov; 31(48):5745-53. PubMed ID: 24091311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of HPV vaccines in the age of nonavalent vaccination.
    Quattrone F; Canale A; Filippetti E; Tulipani A; Porretta A; Lopalco PL
    Minerva Pediatr; 2018 Feb; 70(1):59-66. PubMed ID: 29363293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active Surveillance of Adverse Events Following Human Papillomavirus Vaccination: Feasibility Pilot Study Based on the Regional Health Care Information Platform in the City of Ningbo, China.
    Liu Z; Zhang L; Yang Y; Meng R; Fang T; Dong Y; Li N; Xu G; Zhan S
    J Med Internet Res; 2020 Jun; 22(6):e17446. PubMed ID: 32234696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.